A. Gonenc Et Al. , "Plasma malondialdehyde (MDA) levels in breast and lung cancer patients," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.26, no.2, pp.141-144, 2001
Gonenc, A. Et Al. 2001. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.26, no.2 , 141-144.
Gonenc, A., Ozkan, Y., Torun, M., & Simsek, B., (2001). Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.26, no.2, 141-144.
Gonenc, AYMELEK Et Al. "Plasma malondialdehyde (MDA) levels in breast and lung cancer patients," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.26, no.2, 141-144, 2001
Gonenc, AYMELEK Et Al. "Plasma malondialdehyde (MDA) levels in breast and lung cancer patients." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.26, no.2, pp.141-144, 2001
Gonenc, A. Et Al. (2001) . "Plasma malondialdehyde (MDA) levels in breast and lung cancer patients." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.26, no.2, pp.141-144.
@article{article, author={AYMELEK GÖNENÇ Et Al. }, title={Plasma malondialdehyde (MDA) levels in breast and lung cancer patients}, journal={JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS}, year=2001, pages={141-144} }